McLaren to Expand Into Pharmaceuticals Industry?
We may know McLaren for their exotic sports cars and race cars, but company founder and CEO Ron Dennis recently told the Wall Street Journal that McLaren is looking to expand its $1.5 billion company into other fields – including drugs (the legal kind of course).
As a technology company “first and foremost”, McLaren is looking to “applying the technological savvy evident in decades of Formula One podium finishes to fields like pharmaceuticals and transport management.” And it looks like companies are already interested and are using McLaren’s services.
GlaxoSmithKline is looking into McLaren’s Mission Control center, what McLaren uses to monitor all their F1 races. GlaxoSmithKline believes that McLaren could assist in developing a similar control center for data modeling and high-speed process control.
Currently the United Kingdom’s National Air Traffic Services and California’s rail system utilizes McLaren’s telemetry and predictive ability. Ultimately though, McLaren wants to offer custom solutions in various fields including electronics, pneumatics, kinematics, fluid dynamics, material sciences and to implement their telemetry systems to monitor hospital patients in real time.
Us? Well, we just want to see what McLaren’s second vehicle is going to be in their new lineup.
[Source: Inside Line]
Jason Siu began his career in automotive journalism in 2003 with Modified Magazine, a property previously held by VerticalScope. As the West Coast Editor, he played a pivotal role while also extending his expertise to Modified Luxury & Exotics and Modified Mustangs. Beyond his editorial work, Jason authored two notable Cartech books. His tenure at AutoGuide.com saw him immersed in the daily news cycle, yet his passion for hands-on evaluation led him to focus on testing and product reviews, offering well-rounded recommendations to AutoGuide readers. Currently, as the Content Director for VerticalScope, Jason spearheads the content strategy for an array of online publications, a role that has him at the helm of ensuring quality and consistency across the board.
More by Jason Siu
Comments
Join the conversation